Financial News

Pliant Therapeutics, Inc. - Common Stock (NQ: PLRX )

1.520 -0.060 (-3.80%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pliant Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

Exposures COVID-19

Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump

September 07, 2021

Midway through trading Tuesday, the Dow traded down 0.76% to 35,098.84 while the NASDAQ rose 0.09% to 15,376.87. The S&P also fell, dropping 0.33% to 4,520.38. The U.S. has...

Via Benzinga

Topics Stocks

Exposures US Equities

Why Pliant Therapeutics Stock Is Surging Today

September 07, 2021

A positive phase 2 clinical trial readout was a positive step in the right direction for this biotech start-up.

Via The Motley Fool

45 Stocks Moving In Tuesday's Mid-Day Session

September 07, 2021

Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

September 07, 2021

Gainers Pliant Therapeutics (NASDAQ:PLRX) shares rose 25.62% to $24.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $872.2...

Via Benzinga

Pliant Stock Moves Higher On Positive Data From Pulmonary Fibrosis Trial

September 07, 2021

Pliant Therapeutics Inc (NASDAQ: PLRX) stock is moving higher during the premarket session in reaction to interim results from a Phase 2a positron emission...

Via Benzinga

The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week

September 05, 2021

Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session

September 03, 2021

Gainers Enveric Biosciences (NASDAQ:ENVB...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday

August 20, 2021

On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

41 Stocks Moving In Friday's Mid-Day Session

July 30, 2021

Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute...

Via Benzinga

Exposures Product Safety

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Exposures COVID-19

63 Biggest Movers From Friday

August 02, 2021

Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...

Via Benzinga

Exposures Product Safety

Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021

April 20, 2021

Upgrades Compass Point upgraded the previous rating for Newtek Business Services Corp (NASDAQ:NEWT) from Neutral to Buy. For the fourth quarter, Newtek Business Services...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Pliant Therapeutics, Inc. - Common Stock (NQ: PLRX )

All News about Pliant Therapeutics, Inc. - Common Stock

Popular Pages